NASDAQ: GRAL - GRAIL, LLC

半年間の収益性: +111.82%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール GRAIL, LLC

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について GRAIL, LLC

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2024-06-25
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://grail.com
Цена ао 26.92
1日あたりの価格変動: 0% (29.74)
週ごとの価格変動: -7.32% (32.09)
月ごとの料金変更: -43.44% (52.58)
3ヶ月間の価格変動: +30.78% (22.74)
半年間の価格変動: +111.82% (14.04)
年初からの価格変動: +62.07% (18.35)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0.0202 10
合計: 3.75

効率

名前 意味 学年
ROA, % -32.16 0
ROE, % -40.2 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.1323 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % 537.18 10
収益性 Ebitda, % 155.37 10
収益性 EPS, % 499.75 10
合計: 10
さらに詳しく

ETF共有, %年間の利益率, %配当金, %
Principal Healthcare Innovators ETF 0.04203 618.5 0.8416
Future Tech ETF 0.04203 426.34 0.8416
iShares Russell Mid-Cap Value ETF 0.00401 18.01 2.03934
iShares Russell Midcap ETF 0.00308 20.77 1.71565
iShares Russell 1000 Value ETF 0.00147 17.45 2.15361
iShares U.S. Tech Independence Focused ETF 0.00083 34.94 0.84412
iShares Russell 3000 ETF 0.00067 24.83 1.43482
0.01165.831.41



スーパーバイザー 役職 支払い 生年
Mr. Robert P. Ragusa CEO & Director 1960 (65 年)
Dr. Joshua J. Ofman M.D., M.S.H.S President 1965 (60 年)
Mr. Aaron Freidin Chief Financial Officer
Mr. Paul Ciccolella Senior VP of Global Development & Operations
Ms. Amoolya Singh Ph.D. Senior VP of Research & Chief Scientific Officer
Mr. Abram Barth J.D., M.P.H. General Counsel
Ms. Julie Currie Chief People Officer
Mr. Rodger Currie VP and Head of Government Affairs & Alliance Development
Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng President Biopharma Business & Europe
Dr. Satnam Alag Ph.D. Senior VP of Software Engineering & Chief Security Officer

住所: United States, Menlo Park, 1525 O’Brien Drive - Googleマップで開く, Yandexマップを開く
Webサイト: https://grail.com